Tag: CBMX

GOGO, AZC, PHOT, CBMX & Extended Watchlist

GOGO, Inc.  GOGO

Yesterday after appearing as a focus in our morning report, GOGO responded by posting yet another solid performance. After sinking to a daily low of 27.11, we witnessed a 12% intraday move to 30.26 on twice the 3mo. average volume. That was followed by a strong close, as it held the majority of its gains at 29.70.

The following screenshot captures the activity of the options we were interested in: The 01/18 $30 Calls made a 78% intraday move, and with the way GOGO is trading up pre-market, it’s fair to expect these contracts to be pushed even deeper into the money, adding to our already impressive chances for profit.

Augusta Resources Corp.  AZC

AZC also had a positive showing after yesterday’s report; the stock traded in a range from 1.06-1.25, giving us the opportunity to bank up to an 18% gain. We were correct in assuming that this recovery play was worth our attention, and a return to pre-11/20 levels would still mean significant gains from where it sits now.

Growlife, Inc. PHOT

We’ve continuously covered PHOT for over a year now, and the stock has definitely brought us some prime opportunities for sizable gains, as a quick glance at the chart will show. A recent dip back to the .06-range has been immediately followed by a significant bounce. We are looking at resistance sitting at .095 and from there it has a good chance to re-test recent highs.

We’d like to see higher lows today to confirm that PHOT is indeed back on an uptrend.

To take an even more in-depth look at the PHOT chart, view the video we prepared this morning:

CombiMatrix Corp. CBMX

CBMX came off of yesterday’s extended watchlist to have a big day. The stock opened at 2.48, and would ultimately touch a high of 4.44, which was good for a 79% intraday rip. This came on roughly 48X times the 3mo. average volume, so a stock with this kind of momentum flowing through it will surely continue to be on our watchlist as we close out the week.

Extended Watchlist:
MRIB, ARIA, USU, PVG, POZN, ATRM, ONVO, OIBR,

SAEE, AZC, GOGO & Extended Watchlist

7 Star Entertainment, Inc.  SAEE

SAEE traded sideways yesterday, however we did see a significant amount of volume flow through the stock, to the tune of more than twice the three-month average.

The fact that SAEE didn’t lose any value, and maintained support above a penny is an encouraging sign. We are still on the lookout for further activity on this stock, because as we pointed out yesterday, the chart still looks favorable. A departure from the current holding pattern could certainly lead us to substantial realized gains.

As you can see on the chart below, SAEE is holding support above the 10 and 20DMA’s, and accumulation/distribution is as high as it’s ever been.  We also have an RSI that is registering just below the 50-line, so we’ll be watching for a breach there as well. A PPS break of resistance at .013-.014 could get it there.

All in all, we are still fairly confident in SAEE’s ability to make positive stride from its current level.

Augusta Resources Corp.  AZC

AZC hit our scanners this morning as a potential recovery play. Yesterday the stock tumbled more than 60% from its open just above 1.60, all the way down to the low .60’s. It appears as if we could witness a bounce off of that bottom today as the stock course-corrects following that sell-off.

The huge dip was catalyzed by the announcement that the US Environmental Protection Agency recommended the company’s application for a federal water permit be denied. That effectively puts the company’s plans to build out a copper mining facility on the scrap heap.

Still, whenever we see rapid losses of this magnitude, our thoughts always turn to reaping potential rewards off of the subsequent bounce.

GOGO, Inc. GOGO

We first began talking about GOGO on September 16th, after which time we witnessed an epic run from 14.79-31.55. Last week brought a consolidation and the stock reached a low of 24.24 earlier this week, where it found support just off of the 10DMA. Now that GOGO is headed back up, we will look for it to retest its recent highs.

Options Trading Idea:
On the options side of things, we are looking at GOGO’s 01/18 $30 Calls. They closed at 2.16 yesterday. Hypothetically, should GOGO break out to new highs by January, reaching 35.00, these Calls could be valued at upwards of $5.00 or better.

Extended Watchlist:
OXBT, CRNT, CBMX, ONCY,

ATOS, CTIC, APP & Extended Watchlists

Atossa Genetics, Inc.  ATOS
–
We tacked ATOS onto our extended watchlist yesterday morning, noting that the stock was in the midst of a “Huge gap down” and that we were “watching for a potential bounce”. Indeed that was the case, as the stock touched a low of 2.54 before a reversal carried it as high 3.18, a 25% intraday gain. As usual, when we see big gap-downs, we are looking out for quick-strike opportunities that allow us to make a rapid profit and a timely exit.We have uncovered a few other stocks fitting that profile that we will be monitoring for similar activity today:

Tower Group Intl. Ltd. TWGP

CEL-SCI Corp. CVM

Celgene Corp. CELGZ

Cell Therapeutics, Inc. CTIC
Another play from yesterday’s extended watchlist, CTIC opened at its low of day, and rumbled upward for a 23% move, closing at the high of day on nearly 12X its 3mo. average volume. In doing so, it managed to break a previous swing high at 1.80, a level we’d like to see hold as support moving forward.

We prepared the the following video chart on CTIC:

With the kind of momentum CTIC built up over the course of the day yesterday, this is one play that will be near the top of our watchlists in the near future. The catalyst here seems to be an agreement announced yesterday between the company and the FDA as outlined in the press release below.

SEATTLE, Oct. 7, 2013 /PRNewswire via COMTEX/ — Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced that the company reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the planned pivotal Phase 3 clinical trial, known as the PERSIST-2 trial, evaluating pacritinib compared to best available therapy, including approved JAK2 inhibitors such as ruxolitinib, in patients with myelofibrosis whose platelet counts are <100,000/uL. The SPA is a written agreement between CTI and the FDA regarding the design, endpoints and planned statistical analysis approach of the trial to be used in support of a potential New Drug Application (NDA) submission. The PERSIST-2 trial is the second of two planned Phase 3 clinical trials in patients with myelofibrosis. CTI expects to initiate the PERSIST-2 clinical trial in the fourth quarter of 2013. >>> FULL STORY

American Apparel, Inc. APP

APP is another stock we have tracked for an extended period of time. We have been watching this one to sniff out a bottom for the past few months, and wanted to re-enter it into the conversation today, as that point may be drawing near. A quick peek at the chart below clearly shows just that:

Extended Watchlist:

JCP, AGEN, CBMX, NAVB, TKMR